The largest database of trusted experimental protocols

Ly294002 ly

Manufactured by Merck Group
Sourced in United States

LY294002 (LY) is a chemical compound that functions as a specific inhibitor of phosphoinositide 3-kinase (PI3K), an enzyme involved in various cellular processes. LY is commonly used in research applications to study the role of PI3K and its related signaling pathways.

Automatically generated - may contain errors

16 protocols using ly294002 ly

1

Baicalin's Neuroprotective Effects on TBI

Check if the same lab product or an alternative is used in the 5 most similar protocols
All mice were randomly assigned to the following groups: sham, TBI, TBI + vehicle (V), and TBI + Baicalin (involving three subgroups: 50, 100, and 150 mg/kg). The dose of Baicalin injection used in this study was based on previous studies performed on the cerebral ischemia models.20 (link),25 (link) Baicalin (Sigma-Aldrich Co., St Louis, MO, USA) or equivalent volumes of saline were administered intraperitoneally in the TBI + Baicalin or TBI + V groups for 30 minutes after TBI. The mice used for Neurological Severity Score (NSS) tests were injected with Baicalin or equivalent volumes of saline 30 minutes and every 24 hours after TBI. To further confirm the role of Akt pathway in the neuroprotection of Baicalin on TBI, it was attempted to apply commonly used PI3K/Akt inhibitor, LY294002 (LY) (Sigma-Aldrich Co.). Groups were set as follows: sham, TBI + V, TBI + Baicalin (100 mg/kg), TBI + Baicalin + LY (500 nmol), and TBI + LY (500 nmol). A 5 µL solution of LY was injected into the left ventricle (bregma; 1.0 mm lateral, 0.3 mm posterior, and 2.6 mm deep) for 30 minutes before TBI according to previous studies.26 (link),27 All the mice of each group were euthanized at 24 hours post-TBI except neurobehavioral evaluation.
+ Open protocol
+ Expand
2

Immunomodulation Signaling Pathway Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
F-12 Ham (HF-12) of Dulbecco’s modified Eagle’s medium, bovine serum albumin (BSA), trypsin-EDTA, Igepal CA-930, PGN from S. aureus 77140, Wortmannin (Wort), Akt-i IV, LY294002 (LY), SB216763 (SB), NaCl, LiCl, puromycin, and Bradford reagents were purchased from Sigma-Aldrich, Inc. (St. Louis, MO, USA). Fetal calf serum (FCS) was acquired from Equitech-Bio, Inc. (Kerrville, TX, USA). A cocktail of sodium penicillin G, streptomycin sulfate, and amphotericin B was purchased from Gibco-BRL (Gaithesburg, MD, USA). Akt Inhibitor II, D-3-Deoxy-2-O-methyl-myo-inositol 1-[(R)-2-methoxy-3-(octadecyloxy) propyl hydrogen phosphate (SH-5) was acquired from Calbiochem (Darmstadt, Germany). Halt Phosphatase inhibitor cocktail was purchased from Thermo Fisher Scientific (Waltham, Massachusetts, USA). Protease inhibitor cocktail was acquired from GE Healthcare Bio-sciences (Little Chalfont, UK). Trizol reagent and EXPRESS One-Step SYBR GreenER Universal Kit were purchased from Invitrogen (Carlsbad, CA, USA). Bovine Interleukin 12 (IL-12/p40) TSZ ELISA kit was purchased from Biotang (Massachusetts, USA). All other reagents were acquired from Sigma-Aldrich.
+ Open protocol
+ Expand
3

Lipopolysaccharide-mediated Inflammation Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lipopolysaccharide (Escherichia coli 055:B5) and Ly294002 (Ly) were purchased from Sigma (St Louis, MO, USA).
+ Open protocol
+ Expand
4

Pharmacological Modulation of Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tyrphostin AG1478 (AG) was purchased from Biomol Research Laboratories (Milan, Italy). PD98059 (PD) and Sirtinol were obtained from Calbiochem (Milan, Italy). 1-[4-(-6-Bromobenzol1,3diodo-5-yl)-3a,4,5,9btetrahydro-3H-cyclopenta[c−] quinolin8yl] ethanone (G-1) was purchased from Tocris Bioscience (Bristol, UK). E2, H89, LY294002 (LY) and ETO were purchased from Sigma-Aldrich Srl (Milan, Italy). All compounds were solubilized in dimethyl sulfoxide (DMSO), except E2 and PD which were dissolved in ethanol.
+ Open protocol
+ Expand
5

Feeder-free Adapted Murine Embryonic Stem Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
A feeder-free adapted mES line R1 was propagated as described previously [29 (link)] in an undifferentiated state by cell culturing on tissue culture plastic coated by gelatin (0.1% porcine gelatin solution in water) in Dulbecco's modified Eagle's medium (DMEM) containing 15% fetal bovine serum (FBS), 100 IU/mL penicillin, 0.1 mg/mL streptomycin, 1x nonessential amino acid (all from Gibco-Invitrogen, UK), and 0.05 mM β-mercaptoethanol (Sigma-Aldrich, USA), supplemented with 5 ng/mL of leukemia inhibitory factor (LIF, Chemicon, USA) referred to here as the complete medium.
APO, DPI, hydrogen peroxide (H2O2), N-acetylcysteine (NAC), and LY294002 (LY) were provided from Sigma-Aldrich. Stock solutions of APO (0.4 M), DPI (10 mM), and LY (10 mM) were prepared by dissolving the compounds in dimethyl sulfoxide. Aliquots were stored at −20°C. NAC was prepared as a 0.5 M stock solution in serum-free DMEM medium, pH was adjusted to 7.4, and filter-sterilized aliquots were stored at −20°C. Drugs were added directly to the incubation medium or freshly prediluted in sterile phosphate-buffered saline (PBS) to desired concentration.
+ Open protocol
+ Expand
6

Molecular Signaling Pathway Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-MMP-9 polyclonal goat antibody, anti-β-actin monoclonal mouse antibody, goat anti-rabbit IgG/HRP, goat anti-mouse IgG/HRP, rabbit anti-goat IgG/HRP were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-Phospho-EGFR rabbit mAb, anti-EGFR rabbit mAb, anti-p44/42 MAP Kinase monoclonal rabbit antibody, anti-Phospho-p44/42 MAP Kinase monoclonal rabbit antibody, anti-AKT monoclonal rabbit antibody, anti-Phospho-AKT monoclonal mouse antibody, anti-Phospho-SAPK/JNK (Thr183/Tyr185) (81E11) Rabbit mAb, anti-SAPK/JNK rabbit mAb, anti-Phospho-p38 MAPK (Thr180/Tyr182) (12F8) Rabbit mAb and anti-p38 MAPK rabbit antibody were purchased from Cell Signaling Laboratories (Beverly, MA). PMA (Phorbol-12-myristate-13-acetate), specific inhibitors of PI3K [LY294002 (LY)], MAPK family [PD98059 (PD), mitogen-activated protein kinase kinase (MEK) inhibitor; SP600125 (SP), c-jun N-terminal kinase (JNK) inhibitor and SB203580 (SB), P38 MAPK inhibitor], gelatin and FITC-phalloidin were purchased from Sigma Chemical Co, (St.Louis, MO). PC, cholesterol and PEG4000 were purchased from Sigma Chemical Co, (St.Louis, MO); Honokiol was separated and purified by our laboratory and its purity and structure were analyzed and identified by high performance liquid chromatography and nuclear magnetic resonance [16 ].
+ Open protocol
+ Expand
7

LecB Regulation of Lung Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
H1299 and H1975 lung epithelial cells were grown at 37 °C and 5% CO2 in RPMI-1640 (Gibco) with 10% FCS and 2 mM l-glutamine (Gibco).
Lyophilized, recombinant LecB (Dr. Anne Imberty) was dissolved in PBS (with Ca/Mg) and used at concentrations of 0.09 μM, 0.9 μM and 4.3 μM for indicated time periods. Starvation in serum-free medium was performed, when indicated, for 2 h before treatment and maintained during stimulation. In order to block fucose-binding sites of LecB, l-fucose (Sigma-Aldrich) was directly dissolved in medium, sterile filtered and used at a final concentration of 43 mM for the same time periods as LecB. Other proteins for stimulation purposes were used at the following concentrations: Wnt3a (400 ng/ml, R&D Systems), TNF-α (10 ng/ml, Life Technologies) and staurosporine (Stauro, 1 μM, Sigma-Aldrich). The used inhibitors were pre-incubated for 30 min at 37 °C and maintained during stimulation at following concentrations: lactacystin (Lact, 10 μM, Biomol), bafilomycin (Baf, 0.2 μM, Invivogen), LY294002 (LY, 100 μM, Sigma-Aldrich), triciribine (TCN, 10 μM, Sigma-Aldrich), Akt1/2 inhibitor (Akti, 10 μM, Sigma-Aldrich), TWS119 (TWS, 20 μM, Selleckchem), lithium chloride (LiCl, 20 mM, Roth) and Cycloheximide (Cyclo, 100 μg/ml, Sigma-Aldrich).
+ Open protocol
+ Expand
8

NB Cell Lines Culture and Authentication

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human NB tumor cell lines NB1, NB3, SH-SY5Y, and IMR32, kindly provided by Dr Luca Longo, from IRCCS AOU San Martino – IST, Genoa, Italy, were cultured in RPMI-1640 medium (Sigma-Aldrich, Milan, Italy) with addition of antibiotics (1%), and fetal bovine serum (FBS; 10%; Gibco, Life Technologies, Monza, Italy). DNA typing for the cell line authentication was done prior the analyses. For each experiment, equal numbers of cells were seeded, and the concentration of DMSO equivalent to those of the chemicals used, was applied to control cells. Entrectinib was provided by Ignyta Inc. (San Diego, CA) under a material transfer agreement; Chloroquine (CQ), 3-Methyladenine (3-MA), Tamoxifen (Tam), Rapamycin (Rapa), Ly294002 (Ly), and bovine serum albumin (BSA) were purchased from Sigma-Aldrich, crizotinib from Selleck Chemicals (Munich, Germany). The concentrations of the compounds used in the study were adapted for each experiment before use.
+ Open protocol
+ Expand
9

Investigating Vasodilatory Pharmacology

Check if the same lab product or an alternative is used in the 5 most similar protocols
ANP was purchased from Bachem Holding AG (Bubendorf, Switzerland). CORM-2, CORM-3, Hemin, zinc porphyrin (ZnPP), pinacidil, 5-hydroxydecanoate (5-HD), diltiazem, NG-nitro-L-arginine methyl ester (L-NAME), paxilline, wortamannin, LY-294002 (LY), and 1H-[1 (link),2 (link),4 (link)] oxadiazolo [4,3-a] quinoxalin-1-one (ODQ) were purchased from Sigma-Aldrich (St. Louis, MO, USA).
+ Open protocol
+ Expand
10

Signaling Pathways in TPA-induced AP-1 and NF-κB Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genistein (Sigma Chemical Co., St. Louis, MO, USA) was dissolved in 0.1 M Na2CO3 to create a 10-mM stock solution. TPA (Sigma-Aldrich, St. Louis, MO) was prepared in phosphate-buffered saline (PBS; 137 mM NaCl, 1.4 mM KH2PO4, 4.3 mM Na2HPO4, 2.7 mM KCl, pH 7.2). For analysis of the signaling pathways involved in TPA-induced DNA-binding of AP-1 and NF-κB, we also treated HepG2 cells with the p38 inhibitor SB203580 (SB), the MEK/ERK inhibitor PD98059 (PD), the JNK inhibitor JNKI, the IKK inhibitor BMS (AKTI), LY294002 (LY, an Akt inhibitor) and bisindolylmaleimide (GF, GF109203X, a PKC inhibitor) were purchased from Sigma-Aldrich to block these pathways.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!